Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Respiratory Medicine|January 15, 2025
The impact of blood eosinophil count and FeNO on benralizumab effectiveness in clinical practice: An ORBE II subanalysisIsmael García-Moguel, Álvaro Martínez-Mesa, Rubén Andújar-Espinosa, et al.The Journal of Allergy and Clinical Immunology. in Practice|April 1, 2022
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North AmericaJennifer K Quint, Sofie Arnetorp, Janwillem W H Kocks, et al.Plos One|July 26, 2018
Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort studyMarjan Kerkhof, Trung N Tran, Maarten van den Berge, et al.Chest|April 21, 2025
XALOC-1: Clinical Remission Over 2 Years With Benralizumab in Severe Eosinophilic AsthmaGirolamo Pelaia, David J Jackson, Parameswaran Nair, et al.Journal of Clinical Medicine|November 27, 2025
ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking HabitCarlos Martínez-Rivera, Marina Blanco-Aparicio, Francisco Casas-Maldonado, et al.The European Respiratory Journal|April 4, 2024
Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programmeDavid J Jackson, Girolamo Pelaia, Benjamin Emmanuel, et al.ERJ Open Research|February 7, 2019
Prospective observational study in patients with obstructive lung disease: NOVELTY designHelen K Reddel, Maria Gerhardsson de Verdier, Alvar Agustí, et al.The European Respiratory Journal|February 26, 2021
Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohortHelen K Reddel, Jørgen Vestbo, Alvar Agustí, et al.Respiratory Research|September 28, 2023
Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II studyAlicia Padilla-Galo, Isabel Moya Carmona, Pilar Ausín, et al.Gastroenterologia Y Hepatologia|May 1, 2012
[Current management of nonvariceal upper gastrointestinal bleeding in Spain]Angeles Pérez Aisa, Javier Nuevo, Anibal Alejandro López Morante, et al.Pageof 5